Indevus Investors Sue To Halt Endo Merger
Indevus Pharmaceuticals Inc. has been hit with two putative class actions by shareholders alleging the specialty drug company and its executives breached their fiduciary duties in connection with a merger proposal...To view the full article, register now.
Already a subscriber? Click here to view full article